USC Researchers Identify New Drug Compounds That May Reduce Alzheimer’s Brain Inflammation in High-Risk Patients
May 28, 2026
A team at the University of Southern California has unveiled a set of experimental compounds that may quiet one of the most stubborn drivers of Alzheimer’s disease: chronic inflammation in the brain. The findings, announced on May 26, 2026 and published in the Nature journal npj Drug Discovery, focus on patients carrying APOE4, the strongest known genetic risk factor for late-onset Alzheimer’s. For an estimated 7 million Americans currently living with the disease, and millions
